MHC-II expression to drive a unique pattern of adaptive resistance to antitumor immunity through receptor checkpoint engagement.

被引：7

作者：

Balko, Justin M.

Johnson, Douglas Buckner

Wang, Daniel Ying

Ericsson-Gonzalez, Paula

Nixon, Mellissa

Salgado, Roberto

Sanchez, Violeta

Schreeder, Daniel

Kim, Ju Young

Bordeaux, Jennifer

Sanders, Melinda

Davis, Randall S.

机构：

[1] Vanderbilt Univ Sch Med, Nashville, TN USA

[2] Inst Jules Bordet, Breast Canc Translat Res Lab, Breast Int Grp, Brussels, Belgium

[3] Vanderbilt Univ, Nashville, TN USA

[4] Univ Penn, Philadelphia, PA USA

[5] Navigate BioPharma Serv Inc, Novartis Subsidiary, Carlsbad, CA USA

[6] Univ Alabama Birmingham, Birmingham, AL USA

来源：

关键词：

D O I：

10.1200/JCO.2018.36.5_suppl.180

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

180

引用

页数：2